FDA and CDC are set to call for Johnson & Johnson COVID vaccine to be paused

by

FDA and CDC are set to call for Johnson & Johnson COVID vaccine to be PAUSED after six women out of nearly seven million people developed rare blood clots

  • Seven million people in the U.S. have recieved the Johnson & Johnson vaccine 

By Dailymail.com Reporter

Published: | Updated:

The Food and Drug Administration and the Centers for Disease Control are set to call for Johnson & Johnson’s single-dose vaccine to be stopped in the U.S. after six women developed blood clots.   

The two federal authorities will stop using the vaccine at federal sites and will urge states to do so too, according to officials who have been briefed on the decision, reports the New York Times. 

Seven million people in the U.S. have recieved the Johnson & Johnson vaccine meaning just 0.0001% of those vaccinated had the adverse reaction.

A medical professional from UofL Health administers a vaccine to a patient in their vehicle at University of Louisville Cardinal Stadium in Kentucky on Tuesday

The six recipients who developed the clots were aged between 18 and 48.   

According to the CDC a further nine million shots have been sent to states for distribution.